The Lung Cancer Research Foundation (LCRF) invites Letters of Intent for its 2026 Research Grant on Prevention and Early Detection in Lung Cancer — one of the only dedicated funding mechanisms for researchers focused on reducing lung cancer incidence and catching it earlier. LCRF is the largest organization globally dedicated exclusively to lung cancer research, and this two-year award supports innovative, hypothesis-driven work in prevention and early detection across all histological subtypes. Applications follow a two-step process: a Letter of Intent (LOI) submitted by March 10, 2026, followed by an invited full proposal due June 2, 2026. Applicants may only submit one LCRF application per grant cycle. Funding is up to $150,000 total over two years, and research may be basic, translational, clinical, or epidemiological in nature.
Eligibility Criteria:
- Principal Investigators at academic or nonprofit research institutions worldwide
- Research must focus on lung cancer prevention and/or early detection
- Applicants may only apply for one LCRF grant mechanism per cycle
- LOI submission required as the first step; full proposals are by invitation only
- Institutional sign-off required at the time of full proposal submission
- Full eligibility requirements are specified in the LCRF RFA; applicants should review current guidelines at lcrf.org before applying
Funding Details:
- Award amount: Up to $150,000 total over two years
- Funds may cover personnel, supplies, and research-related expenses (per RFA guidelines)
- Two-year project duration
- Allowable costs and indirect cost policy detailed in LCRF’s current RFA document
Deadline:
- LOI Deadline: March 10, 2026 (URGENT — 6 days away)
- LOI notification (invited to full proposal): April 28, 2026
- Full Proposal Deadline: June 2, 2026 (invitation only)
- Applications submitted via LCRF’s online portal; confirm submission platform at lcrf.org
Contact / Further Information: